NHS England
The main aim of NHS England is to improve the health outcomes for people in England. They believe the new approach they are taking will really make a difference and deliver the improved health outcomes they all want to see. Central to their ambition is to place the patients and the public at the heart of everything they do. They are what they want the NHS to be – open, evidence-based and inclusive, to be transparent about the decisions they make, the way they operate and the impact they have. They encourage patient and public participation in the NHS, treat them respectfully and put their interests first. This allows us to develop the insight to help us improve outcomes and guarantee no community is left behind or disadvantaged. They empower and support clinical leaders at every level of the NHS through clinical commissioning groups (CCGs), networks and senates, in NHS England itself and in providers, helping them to make genuinely informed decisions, spend the taxpayers’ money wisely and provide high quality services. Engaging with their staff is equally important to us too. Their staff are what makes NHS England an excellent organisation: an exemplar in customer focus, professionalism, rigour and creativity. Grounded by the values and principles of the NHS Constitution, they are an organisation who shares ideas and knowledge, successes and failures, and listens to each other carefully and thoughtfully. At NHS England, they practice what they preach. By working collaboratively and building coalitions with partners everywhere means they can achieve greater things together and deliver the best patient service not only in England but in the world.
Ibex Medical Analytics Ltd, based in Tel Aviv, Israel, specializes in developing AI-based systems for cancer diagnosis in pathology. The company's flagship product, the Ibex Second Read system, operates alongside human pathologists to analyze medical cases, identifying discrepancies between human diagnoses and its AI-driven analysis. By integrating artificial intelligence, data science, and image analysis with digitized glass slides and electronic medical records, Ibex aims to improve clinical decision-making and streamline pathology workflows. The technology is designed to reveal underlying patterns in data, providing valuable clinical insights that enhance the accuracy and speed of diagnoses. Ultimately, Ibex Medical Analytics is focused on advancing cancer care and improving patient outcomes and quality of life through innovative diagnostic solutions.
Tommy's is a charity that carries out research into the causes of miscarriage, stillbirth, and premature birth. They support them throughout their entire pregnancy journey from conception to postpartum recovery. Their free digital tools, calculators, and resources will help them have a healthy and happy pregnancy. All the information and support they need, including tools and news, and stories covering the entire pregnancy.
Cibiltech SAS is a Paris-based company that specializes in developing digital solutions for predictive medicine in renal transplantation. Founded in 2019, the company has created Predigraft, an artificial intelligence platform designed for post-transplantation monitoring. This platform utilizes advanced algorithms to assist nephrologists in assessing the individual graft loss trajectory for each patient. By providing timely insights, Cibiltech's technology enables healthcare providers to tailor treatments more effectively, leading to improved graft survival, extended patient lifespans, and optimized management of clinical resources.
Medtronic is a leading global company based in the United States, founded in 1949, that specializes in the development and manufacturing of medical technologies and therapies. The firm focuses on creating innovative solutions for chronic diseases and pain management, offering device-based treatments that aim to improve patient outcomes and enhance quality of life. Medtronic's extensive range of products and services addresses various health conditions, demonstrating its commitment to advancing healthcare technology. In addition to its core business, Medtronic also manages venture capital initiatives, such as the Suzhou Medtronic RMB Fund, which aims to invest in healthcare innovations in China. The company is dedicated to delivering lifelong solutions for individuals suffering from chronic health issues.
Icometrix is a company based in Leuven, Belgium, specializing in the development of automated MRI biomarkers for neurological disorders. Founded in 2011 as a spin-off from the universities and university hospitals of Leuven and Antwerp, the company provides standardized measurements of brain MRI scans to enhance personalized care for patients with conditions such as multiple sclerosis, dementia, and traumatic brain injury. Its key products include icobrain ms, which tracks disease progression in multiple sclerosis patients; cobrain dm, which quantifies brain structures in dementia patients; and icobrain tbi, which monitors axonal injuries in head trauma cases. Icometrix has gained international recognition for its solutions, which are widely used in clinical practice and research, including clinical trials for new drug development. The company is ISO certified for quality management and information security, and its software-as-a-service platform enables efficient processing of large volumes of brain imaging data, contributing to advancements in the understanding and treatment of neurological disorders.
InSightec is the pioneer and global leader in MR guided focused ultrasound technology for image guided acoustic surgery.
ExAblate® 2000 system was the first system to use the MR guided focused ultrasound technology. The ExAblate system received CE mark in 2002 and the Food and Drug Administration (FDA) approval in 2004 for the treatment of symptomatic uterine fibroids. ExAblate received the European CE Mark for pain palliation of bone metastases in June 2007 and for adenomyosis in June 2010. This device has won numerous innovation awards and has been used to treat thousands of patients around the world.
Optos plc is a retinal imaging company based in Dunfermline, United Kingdom, that specializes in the design, development, manufacturing, and marketing of ultra-widefield (UWF) imaging devices for eye-care professionals globally. Founded in 1992, the company produces high-resolution optomap images that facilitate the early detection and management of various retinal disorders, including diabetic retinopathy, glaucoma, and age-related macular degeneration. Its product lineup includes advanced imaging devices such as the California af, California fa, California icg, Daytona, and Monaco, each tailored to different clinical needs and patient care levels. Additionally, Optos offers integrated software solutions, including OptosAdvance for clinical data management and OptosCloud for image storage. These innovations aim to enhance the capabilities of eye-care professionals while improving patient outcomes. Optos operates as a subsidiary of Nikon Corporation.
Inovus Ltd specializes in designing and manufacturing medical simulation products aimed at enhancing surgical training. Founded in 2012 and based in Saint Helens, United Kingdom, the company offers a range of simulators, including take-home and institutional laparoscopic simulators. These products are specifically developed to teach essential surgical skills, such as laparoscopic appendectomy and cholecystectomy, as well as competencies in critical care and medicine. Inovus Ltd caters to its customers primarily through online channels, providing accessible and versatile training solutions for surgical trainees and residents to improve their skills and ultimately enhance patient care.
Corporation Pop designs original and engaging interactive tools that help their clients communicate with their audience. Founded in 2007, the company is headquartered in Manchester, Manchester, United Kingdom.
Non Equity Assistance in 2014
Blue Maestro is a leading designer and developer of connected products and solutions, from consumer devices through to their work with NHS England on the next generation of medicine adherence sensors. They have a number of innovative products and solutions under development, several that are patent pending. Meet some of Blue Maestro’s management team below.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.